Dr. Reddy's Laboratories targeting to triple reach to 1.5 billion patients by 2030

07 Jul 2022 Evaluate

Dr. Reddy's Laboratories is targeting to triple its reach to 1.5 billion patients by 2030 as part of its sustainability goals. Under its sustainability goals for the next decade, it is making its products accessible and affordable for patients and 25 per cent of new launches to be first to market by 2027.

Besides, by 2030 the company will use 100 per cent renewable power and it will also be carbon-neutral in direct emissions, while it is targeting 12.5 per cent reduction in indirect carbon emissions.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1224.30 -15.70 (-1.27%)
28-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1331.80
Zydus Lifesciences 896.60
Lupin 2132.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×